Doosan Fuel Cell (A336260) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Jun, 2026Executive summary
Q3 2025 revenue was KRW 319.0 billion, with an operating loss of KRW 29.1 billion, mainly from fuel cell equipment (77%) and long-term maintenance (23%), and increased SOFC-related costs.
Maintains leading domestic market share (49% of cumulative installed capacity) and is expanding into overseas markets and new business areas such as SOFC and hydrogen mobility.
Year-over-year sales grew 18.4%, but profitability declined as gross profit turned negative and net loss widened.
Significant order growth is expected in 2025, driven by CHPS market wins and overseas expansion, with sales projected to double within five years if a 50% market share is achieved.
R&D investment continues, with 1.0% of sales allocated to development, focusing on cost reduction, new product development, and future hydrogen infrastructure.
Financial highlights
Q3 2025 consolidated revenue: KRW 319.0 billion; operating loss: KRW 29.1 billion; net loss: KRW 30.2 billion.
Gross margin dropped to -6.5% (consolidated), EBITDA margin to -9.8%.
Debt-to-equity ratio increased to 178% (consolidated), with net borrowings rising to KRW 439.4 billion.
Cash and cash equivalents decreased to KRW 72.4 billion.
Total assets: KRW 1,304.6 billion; total liabilities: KRW 835.5 billion; equity: KRW 469.1 billion.
Outlook and guidance
Orders for 2025 are set to rise sharply, reflecting 127MW of CHPS projects and new overseas contracts.
Mid- to long-term sales outlook projects a 15% CAGR, with potential to double sales by 2029.
Expansion into data center and distributed energy markets is expected to drive future growth.
Anticipates accelerated growth in the hydrogen economy and fuel cell market due to government policy and CHPS implementation.
Plans to expand business models, strengthen cost competitiveness, and pursue overseas and new hydrogen-related businesses.
Latest events from Doosan Fuel Cell
- Sales jumped 173% QoQ in 2Q24, with new H2 models and SOFC investments boosting outlook.A336260
Q2 202424 Jun 2026 - Revenue fell sharply with a net loss, but CHPS orders and SOFC growth support a rebound.A336260
Q3 202424 Jun 2026 - Q1 2025 sales tripled YoY to KRW 99.8B, but losses widened amid ongoing expansion.A336260
Q1 202524 Jun 2026 - H1 2025 revenue was KRW 228.2bn, with narrowing losses and strategic expansion underway.A336260
Q2 202524 Jun 2026 - Q1 2026 revenue up 45% YoY, operating loss narrows, and EBITDA turns positive.A336260
Q1 202629 Apr 2026 - 2025 saw sales growth but deeper losses, with strong sales and order growth expected from 2026.A336260
Q4 202516 Mar 2026 - Sales up 58% YoY, CHPS market share at 73%, net loss due to higher costs, strong 2025 outlook.A336260
Q4 202420 Feb 2026